The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116131364 11613136 4 F 20130710 20160712 20151008 20160912 PER US-JNJFOC-20150903660 JANSSEN 67.22 YR E M Y 0.00000 20160912 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116131364 11613136 1 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 2 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 3 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 4 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 5 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 6 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 7 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 8 SS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 0 TABLET
116131364 11613136 9 PS XARELTO RIVAROXABAN 1 Oral 10 AND 20 MG U U 202439 TABLET
116131364 11613136 10 SS PLAVIX CLOPIDOGREL BISULFATE 1 Unknown U 0 UNSPECIFIED
116131364 11613136 11 C LISINOPRIL. LISINOPRIL 1 Unknown 0 UNSPECIFIED
116131364 11613136 12 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown 0 UNSPECIFIED
116131364 11613136 13 C CARVEDILOL. CARVEDILOL 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116131364 11613136 1 Atrial fibrillation
116131364 11613136 2 Atrial fibrillation
116131364 11613136 3 Atrial fibrillation
116131364 11613136 4 Embolism
116131364 11613136 5 Embolism
116131364 11613136 6 Embolism
116131364 11613136 7 Cerebrovascular accident prophylaxis
116131364 11613136 8 Cerebrovascular accident prophylaxis
116131364 11613136 9 Cerebrovascular accident prophylaxis
116131364 11613136 10 Product used for unknown indication
116131364 11613136 11 Product used for unknown indication
116131364 11613136 12 Product used for unknown indication
116131364 11613136 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
116131364 11613136 OT
116131364 11613136 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116131364 11613136 Internal haemorrhage
116131364 11613136 Rectal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116131364 11613136 1 20150304 0
116131364 11613136 2 20120416 2012 0
116131364 11613136 3 20130101 20130701 0
116131364 11613136 4 20150304 0
116131364 11613136 5 20120416 2012 0
116131364 11613136 6 20130101 20130701 0
116131364 11613136 7 20130101 20130701 0
116131364 11613136 8 20150304 0
116131364 11613136 9 20120416 2012 0